Tepotinib in patients (pts) with METexon 14 (METex14) skipping NSCLC: Efficacy results from all pts enrolled in VISION cohort A Meeting Abstract


Authors: Scherz, A.; Sakai, H.; Le, X.; Felip, E.; Veillon, R.; Garassino, M. C.; Raskin, J.; Viteri, S.; Mazieres, J.; Cortot, A.; Smit, E.; Thomas, M.; Conte, P.; Gottfried, M.; Britschgi, C.; Bruns, R.; Otto, G.; Johne, A.; Paik, P.
Abstract Title: Tepotinib in patients (pts) with METexon 14 (METex14) skipping NSCLC: Efficacy results from all pts enrolled in VISION cohort A
Meeting Title: European Lung Cancer Virtual Congress (ELCC 2021 Virtual)
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 4 Suppl.
Meeting Dates: 2021 Mar 25-27
Meeting Location: Virtual Conference
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-04-01
Start Page: S783
End Page: S784
Language: English
ACCESSION: WOS:000634855900155
PROVIDER: wos
DOI: 10.1016/S1556-0864(21)01999-7
Notes: Meeting Abstract: 157P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik